Banerjee D - Search Results

1

Bansal N, Banerjee D. Bansal N, et al. Among authors: banerjee d. Curr Pharm Biotechnol. 2009 Feb;10(2):192-6. doi: 10.2174/138920109787315015. Curr Pharm Biotechnol. 2009. PMID: 19199951 Review.

2

A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts.

Xie X, Bansal N, Shaik T, Kerrigan JE, Minko T, Garbuzenko O, Abali EE, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Xie X, et al. Among authors: banerjee d. Oncotarget. 2014 Feb 28;5(4):901-7. doi: 10.18632/oncotarget.1809. Oncotarget. 2014. PMID: 24658650 Free PMC article.

3

Species-specific differences in translational regulation of dihydrofolate reductase.

Hsieh YC, Skacel NE, Bansal N, Scotto KW, Banerjee D, Bertino JR, Abali EE. Hsieh YC, et al. Among authors: banerjee d. Mol Pharmacol. 2009 Oct;76(4):723-33. doi: 10.1124/mol.109.055772. Epub 2009 Jul 1. Mol Pharmacol. 2009. PMID: 19570950 Free PMC article.

4

Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer.

Shaik T, Rather GM, Bansal N, Minko T, Garbuzenko O, Szekely Z, Abali EE, Banerjee D, Kerrigan JE, Scotto KW, Bertino JR. Shaik T, et al. Among authors: banerjee d. Oncotarget. 2018 Sep 7;9(70):33249-33257. doi: 10.18632/oncotarget.26064. eCollection 2018 Sep 7. Oncotarget. 2018. PMID: 30279956 Free PMC article.

5

Molecular targets for epigenetic therapy of cancer.

Humeniuk R, Mishra PJ, Bertino JR, Banerjee D. Humeniuk R, et al. Among authors: banerjee d. Curr Pharm Biotechnol. 2009 Feb;10(2):161-5. doi: 10.2174/138920109787315123. Curr Pharm Biotechnol. 2009. PMID: 19199948 Review.

6

Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment.

Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, Banerjee D. Rattigan YI, et al. Among authors: banerjee d. Exp Cell Res. 2012 Feb 15;318(4):326-35. doi: 10.1016/j.yexcr.2011.11.014. Epub 2011 Dec 8. Exp Cell Res. 2012. PMID: 22178238 Free PMC article.

7

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.

Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D. Rattigan Y, et al. Among authors: banerjee d. Exp Cell Res. 2010 Dec 10;316(20):3417-24. doi: 10.1016/j.yexcr.2010.07.002. Epub 2010 Jul 13. Exp Cell Res. 2010. PMID: 20633553

8

The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.

Lin SY, Yang J, Everett AD, Clevenger CV, Koneru M, Mishra PJ, Kamen B, Banerjee D, Glod J. Lin SY, et al. Among authors: banerjee d. Exp Cell Res. 2008 Oct 15;314(17):3107-17. doi: 10.1016/j.yexcr.2008.07.028. Epub 2008 Aug 8. Exp Cell Res. 2008. PMID: 18722367 Free PMC article.

9

Mesenchymal stem cells: flip side of the coin.

Mishra PJ, Mishra PJ, Glod JW, Banerjee D. Mishra PJ, et al. Among authors: banerjee d. Cancer Res. 2009 Feb 15;69(4):1255-8. doi: 10.1158/0008-5472.CAN-08-3562. Epub 2009 Feb 10. Cancer Res. 2009. PMID: 19208837 Review.

10

Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells.

Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D. Menon LG, et al. Among authors: banerjee d. Stem Cells. 2007 Feb;25(2):520-8. doi: 10.1634/stemcells.2006-0257. Epub 2006 Oct 19. Stem Cells. 2007. PMID: 17053212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,908 results

Search Page